Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
60.8M
-
Shares change
-
-4M
-
Total reported value, excl. options
-
$258M
-
Value change
-
-$142M
-
Put/Call ratio
-
1.81
-
Number of buys
-
74
-
Number of sells
-
-89
-
Price
-
$4.25
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q2 2024
199 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q2 2024.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.8M shares
of 62M outstanding shares and own 98.1% of the company stock.
Largest 10 shareholders include Bellevue Group AG (9.94M shares), ARMISTICE CAPITAL, LLC (6M shares), BlackRock Inc. (5.4M shares), VANGUARD GROUP INC (4.14M shares), MILLENNIUM MANAGEMENT LLC (3.31M shares), Frazier Life Sciences Management, L.P. (3.01M shares), WASATCH ADVISORS LP (2.45M shares), RA CAPITAL MANAGEMENT, L.P. (2.08M shares), STATE STREET CORP (1.54M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.42M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.